Braskem (NYSE:BAK - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Thursday, May 8th. Analysts expect Braskem to post earnings of $0.06 per share and revenue of $22.86 billion for the quarter.
Braskem (NYSE:BAK - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.38) by ($0.01). The firm had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.52 billion. Braskem had a negative return on equity of 439.59% and a negative net margin of 9.88%. On average, analysts expect Braskem to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Braskem Trading Up 2.4 %
Shares of BAK stock traded up $0.09 during mid-day trading on Tuesday, reaching $3.63. The stock had a trading volume of 69,098 shares, compared to its average volume of 843,709. Braskem has a 1-year low of $2.85 and a 1-year high of $8.09. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of -1.02 and a beta of 1.83. The business's fifty day moving average is $3.64 and its 200-day moving average is $4.38.
Wall Street Analysts Forecast Growth
Separately, Scotiabank downgraded shares of Braskem from a "sector outperform" rating to a "sector perform" rating in a report on Monday, March 3rd.
View Our Latest Stock Report on Braskem
Braskem Company Profile
(
Get Free Report)
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Featured Articles

Before you consider Braskem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.
While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.